Table 1 Baseline features of eyes with steroid associated CSC (group A) and those with idiopathic CSC (group B)
From: Retinal and choroidal changes in steroid-associated central serous chorioretinopathy
Baseline features | Group A (N = 20 eyes of 16 patients) | Group A (N = 30 eyes of 28 patients) | P value |
|---|---|---|---|
Age (years ± SD) | 45 ± 16.13 | 43.3 ± 9.45 | 0.77 |
Male: female (n) | 12:8 | 5:25 | < 0.01* |
Bilaterality | 6/20 (30%) | 2/30 (6.67%) | 0.03* |
Duration of symptoms (days ± SD) | 105.83 ± 96.10 | 107.13 ± 138.70 | 0.98 |
Baseline BCVA (Snellen ± SD logMAR) | 20/33 ± 0.34 | 20/40 ± 0.27 | 0.06 |